These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 34411974)

  • 1. Generation of three induced pluripotent stem cell lines (SCVIi014-A, SCVIi015-A, and SCVIi016-A) from patients with LQT1 caused by heterozygous mutations in the KCNQ1 gene.
    Zhang H; Jahng JWS; Liu Y; Chase AJ; Perez MV; Wu JC
    Stem Cell Res; 2021 Aug; 55():102492. PubMed ID: 34411974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of eight human induced pluripotent stem cell (iPSC) lines from familial Long QT Syndrome type 1 (LQT1) patients carrying KCNQ1 c.1697C>A mutation (NUIGi005-A, NUIGi005-B, NUIGi005-C, NUIGi006-A, NUIGi006-B, NUIGi006-C, NUIGi007-A, and NUIGi007-B).
    Ge N; Liu M; Krawczyk J; McInerney V; Galvin J; Shen S; O'Brien T; Prendiville T
    Stem Cell Res; 2019 Aug; 39():101502. PubMed ID: 31415974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of induced pluripotent stem cell lines from patients with LQT1 caused by heterozygous mutations in the KCNQ1 gene.
    Ren L; Jahng JWS; Belbachir N; Cook Z; Rivero GC; Perez MV; Wu JC
    Stem Cell Res; 2024 Aug; 78():103443. PubMed ID: 38763038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation and characterization of twelve human induced pluripotent stem cell (iPSC) lines from four familial long QT syndrome type 1 (LQT1) patients carrying KCNQ1 c.1201dupC mutation.
    Ge N; Liu M; Ding Y; Krawczyk J; McInerney V; Galvin J; Shen S; Prendiville T; O'Brien T
    Stem Cell Res; 2019 Dec; 41():101650. PubMed ID: 31765965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment of a human induced pluripotent stem cell line, KSCBi015-A, from a long QT syndrome type 1 patient harboring a KCNQ1 mutation.
    Lee Y; Park H; Kyung Koo S; Kim JH
    Stem Cell Res; 2021 Oct; 56():102521. PubMed ID: 34509919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of a human induced pluripotent stem cell line (JSPHi002-A) from a patient with long-QT syndrome type 1 caused by KCNQ1 c.773A > T mutation.
    Wang Q; Zhang Y; Zhang F; Li Z; Cheng H; Lin Y; Zhu Y; Chen H; Cui C; Chen M
    Stem Cell Res; 2022 Jul; 62():102810. PubMed ID: 35580545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression-Replacement
    Dotzler SM; Kim CSJ; Gendron WAC; Zhou W; Ye D; Bos JM; Tester DJ; Barry MA; Ackerman MJ
    Circulation; 2021 Apr; 143(14):1411-1425. PubMed ID: 33504163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a novel KCNQ1 mutation for type 1 long QT syndrome and assessment of the therapeutic potential of a novel IKs activator using patient-specific induced pluripotent stem cell-derived cardiomyocytes.
    Ma D; Wei H; Lu J; Huang D; Liu Z; Loh LJ; Islam O; Liew R; Shim W; Cook SA
    Stem Cell Res Ther; 2015 Mar; 6(1):39. PubMed ID: 25889101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complex aberrant splicing in the induced pluripotent stem cell-derived cardiomyocytes from a patient with long QT syndrome carrying KCNQ1-A344Aspl mutation.
    Wuriyanghai Y; Makiyama T; Sasaki K; Kamakura T; Yamamoto Y; Hayano M; Harita T; Nishiuchi S; Chen J; Kohjitani H; Hirose S; Yokoi F; Gao J; Chonabayashi K; Watanabe K; Ohno S; Yoshida Y; Kimura T; Horie M
    Heart Rhythm; 2018 Oct; 15(10):1566-1574. PubMed ID: 29857160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of three heterozygous KCNH2 mutation-carrying human induced pluripotent stem cell lines for modeling LQT2 syndrome.
    Mondéjar-Parreño G; Jahng JWS; Belbachir N; Wu BC; Zhang X; Perez MV; Badhwar N; Wu JC
    Stem Cell Res; 2021 Jul; 54():102402. PubMed ID: 34051449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of a human embryonic stem cell line WAe009-A-79 carrying a long QT syndrome mutation in KCNQ1.
    Wang H; Guo T; Lan F
    Stem Cell Res; 2023 Aug; 70():103119. PubMed ID: 37244124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the I
    Zhong L; Yan Z; Jiang D; Weng KC; Ouyang Y; Zhang H; Lin X; Xiao C; Yang H; Yao J; Kang X; Wang C; Huang C; Shen B; Chung SK; Jiang ZH; Zhu W; Neher E; Silva JR; Hou P
    Circ Res; 2024 Sep; 135(7):722-738. PubMed ID: 39166328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation and characterization of the human induced pluripotent stem cell (hiPSC) line NCUFi001-A from a patient carrying KCNQ1 G314S mutation.
    Lavra L; Magi F; Ulivieri A; Morgante A; Paulis M; Sala L; Pedrazzini M; Polisca P; Rocchetti M; Calò L; Sciacchitano S; Salehi LB
    Stem Cell Res; 2021 Jul; 54():102418. PubMed ID: 34130155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A KCNQ1 mutation contributes to the concealed type 1 long QT phenotype by limiting the Kv7.1 channel conformational changes associated with protein kinase A phosphorylation.
    Bartos DC; Giudicessi JR; Tester DJ; Ackerman MJ; Ohno S; Horie M; Gollob MH; Burgess DE; Delisle BP
    Heart Rhythm; 2014 Mar; 11(3):459-68. PubMed ID: 24269949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studying KCNQ1 Mutation and Drug Response in Type 1 Long QT Syndrome Using Patient-Specific Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Wei H; Wu J; Liu Z
    Methods Mol Biol; 2018; 1684():7-28. PubMed ID: 29058180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variants in the 3' untranslated region of the KCNQ1-encoded Kv7.1 potassium channel modify disease severity in patients with type 1 long QT syndrome in an allele-specific manner.
    Amin AS; Giudicessi JR; Tijsen AJ; Spanjaart AM; Reckman YJ; Klemens CA; Tanck MW; Kapplinger JD; Hofman N; Sinner MF; Müller M; Wijnen WJ; Tan HL; Bezzina CR; Creemers EE; Wilde AA; Ackerman MJ; Pinto YM
    Eur Heart J; 2012 Mar; 33(6):714-23. PubMed ID: 22199116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular Mechanism of Autosomal Recessive Long QT-Syndrome 1 without Deafness.
    Oertli A; Rinné S; Moss R; Kääb S; Seemann G; Beckmann BM; Decher N
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33498651
    [No Abstract]   [Full Text] [Related]  

  • 18. Patient-specific induced pluripotent stem-cell models for long-QT syndrome.
    Moretti A; Bellin M; Welling A; Jung CB; Lam JT; Bott-Flügel L; Dorn T; Goedel A; Höhnke C; Hofmann F; Seyfarth M; Sinnecker D; Schömig A; Laugwitz KL
    N Engl J Med; 2010 Oct; 363(15):1397-409. PubMed ID: 20660394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of three induced pluripotent stem cell lines, SCVIi003-A, SCVIi004-A, SCVIi005-A, from patients with ARVD/C caused by heterozygous mutations in the PKP2 gene.
    Jahng JWS; Black KE; Liu L; Bae HR; Perez M; Ashley EA; Sallam K; Wu JC
    Stem Cell Res; 2021 May; 53():102284. PubMed ID: 33743362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KCNQ1 mutations associated with Jervell and Lange-Nielsen syndrome and autosomal recessive Romano-Ward syndrome in India-expanding the spectrum of long QT syndrome type 1.
    Vyas B; Puri RD; Namboodiri N; Nair M; Sharma D; Movva S; Saxena R; Bohora S; Aggarwal N; Vora A; Kumar J; Singh T; Verma IC
    Am J Med Genet A; 2016 Jun; 170(6):1510-9. PubMed ID: 27041150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.